Parnell Pharmaceuticals Holdings Ltd
PARN
PARN was delisted on the 30th of December, 2016.
1 hedge funds and large institutions have $0 invested in Parnell Pharmaceuticals Holdings Ltd in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $96K → $0 (-$96K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$96K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Alyeska Investment Group
Chicago,
Illinois
| – | -$96K | -147,458 | Closed |
|
PARN Hedge Fund Activity: Q4 2017 in Review
1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q4 2017, worth a combined $0 — down 100% from $96K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PARN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Alyeska Investment Group, exiting entirely with an estimated $96K sold.
- 1 institutional investor held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q4 2017, down from 2 in Q3 2017.
- Funds reported $0 of Parnell Pharmaceuticals Holdings Ltd stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest Parnell Pharmaceuticals Holdings Ltd seller in Q4 2017 was Alyeska Investment Group, an estimated $96K sold.
Based on aggregated 13F filings for Q4 2017.